Background Helicobacter pylori (H. pylori) is a bacterial infection that is prevalent and affects
more than half of the world's population, causing stomach disorders such as gastritis, peptic …

Clostridioides difficile is a Gram-positive, spore-forming, anaerobic bacterium. The clinical
features of C. difficile infections (CDIs) can vary, ranging from the asymptomatic carriage and …

ABSTRACT Introduction Updating data on Clostridioides difficile antibiotic resistance is
important for treatment improvement of C. difficile infections (CDIs). Areas covered Results …

Antimicrobial peptides (AMPs) are molecules with an amphipathic structure that enables
them to interact with bacterial membranes. This interaction can lead to membrane crossing …

Clostridioides difficile infection (CDI) remains a significant contributor to healthcare costs
and morbidity due to high rates of recurrence. Currently, available antibiotic treatment …

Abstract RBX2660 (fecal microbiota, live-jslm; REBYOTA®) is an emerging option for the
prevention of recurrent Clostridioides difficile infection (CDI) following standard of care …

艰难梭菌(Clostridioides difficil, CD) 是医疗机构感染性腹泻最常见的病原之一,
并被美国疾病控制和预防中心列为需要紧急和积极应对的耐药威胁. 许多耐药基因可在医疗机构 …

Clostridioides difficile is a Gram-positive, spore-forming anaerobic bacterial pathogen that
causes severe gastrointestinal infection in humans. This review provides background …

Secondary active transporters shuttle substrates across eukaryotic and prokaryotic
membranes, utilizing different electrochemical gradients. They are recognized as one of the …

Gut microbiome-modulating agents (MMAs), including probiotics, prebiotics, postbiotics, and
synbiotics, are shown to ameliorate type 1 diabetes (T1D) by restoring the microbiome from …